Robert M. DiFazio

Co-Founder & CEO at Parallel Bio
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Cambridge, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • Co-Founder & CEO
      • May 2021 - 2 years 8 months

      Cambridge, Massachusetts, United States

    • United States
    • Higher Education
    • 700 & Above Employee
    • Director, Office of Strategy and Research Development, ITI
      • Aug 2017 - May 2021

      Stanford, CA I created the Office of Strategy and Research Development with the Institute for Immunity, Transplantation, and Infection (ITI) within which I work to identify opportunities, develop strategy, and lead, implement, and administer large academic programs. I serve as expert advisor to faculty and staff and direct program/entity strategy development, long- range planning, and partnership development.

    • United States
    • Higher Education
    • 700 & Above Employee
    • Graduate Student Researcher
      • Jun 2011 - Feb 2017

      Greater Pittsburgh Area Advisor: JoAnne L. Flynn, PhD, Department of Microbiology and Molecular Genetics --Determine the immune responses that lead to pulmonary fibrosis after drug treatment in the non-human primate model of tuberculosis. (Jan. 2012-Jan. 2016) --Use PET-CT and immune markers to determine predictive markers of protective immunity to tuberculosis and determine early events in the granulomas of protected animals (Jan. 2013-Jun. 2016) --Evaluate efficacy of prime-boost vaccination in the rhesus… Show more Advisor: JoAnne L. Flynn, PhD, Department of Microbiology and Molecular Genetics --Determine the immune responses that lead to pulmonary fibrosis after drug treatment in the non-human primate model of tuberculosis. (Jan. 2012-Jan. 2016) --Use PET-CT and immune markers to determine predictive markers of protective immunity to tuberculosis and determine early events in the granulomas of protected animals (Jan. 2013-Jun. 2016) --Evaluate efficacy of prime-boost vaccination in the rhesus macaque model of tuberculosis (June 2013-Jan. 2017)

    • Instructor
      • Sep 2012 - Dec 2016

      Immunology of Infectious Diseases (Fall 2016) Director: JoAnne L. Flynn, PhD Medical Microbiology (Spring 2014) Laboratory Director: Jennifer Bomberger, PhD Medical Microbiology (Spring 2013) Laboratory Director: Carolyn Coyne, PhD Foundations of Biomedical Science (Fall 2012) Discussion Director: Wendy Mars, PhD

    • United States
    • Higher Education
    • 700 & Above Employee
    • Campus Tour Guide
      • Sep 2009 - Apr 2011

      I performed similar duties to my "Incoming Student Liaison" role in addition to giving campus tours, engineering campus tours, and liaising with the parents and guardians of prospective students.

    • Teaching Assistant
      • Sep 2009 - Apr 2011

      CHEM 104- Chemistry II (Spring 2011) Course Professor: Christian Ray, PhD CHEM 102- Chemistry I (Fall 2010) Course Professor: Chris Yerkes, PhD CHEM 103- Chemistry Lab I (Spring 2010) Course Professor: Erin Whitteck, PhD CHEM 203- Accelerated Chemistry Lab I (Fall 2009) Course Professor: Elizabeth Glogowski, PhD

    • Undergraduate Research Assistant
      • Jan 2009 - Apr 2011

      Urbana-Champaign, Illinois Area Advisor: Paul J. Hergenrother, PhD, Department of Chemistry --Evaluate the utility of toxin-antitoxin (TA) systems as a novel antibacterial target and determine the prevalence and functionality of genes encoding TA systems in bacterial clinical isolates. (Jan. 2009-Feb. 2011) --Validate assay for specific high throughput screen to identify small molecules capable of disrupting the interactions between the toxin and antitoxin, thus enabling the toxin to kill the pathogen. (Jun. 2010-Aug… Show more Advisor: Paul J. Hergenrother, PhD, Department of Chemistry --Evaluate the utility of toxin-antitoxin (TA) systems as a novel antibacterial target and determine the prevalence and functionality of genes encoding TA systems in bacterial clinical isolates. (Jan. 2009-Feb. 2011) --Validate assay for specific high throughput screen to identify small molecules capable of disrupting the interactions between the toxin and antitoxin, thus enabling the toxin to kill the pathogen. (Jun. 2010-Aug. 2010)

    • Incoming Student Liaison
      • May 2009 - Sep 2009

      I assisted incoming freshmen with registering for classes and adjusting to campus life.

Education

  • Stanford University School of Medicine
    Postdoctoral Fellowship, Systems Immunology
  • University of Pittsburgh School of Medicine
    Doctor of Philosophy (Ph.D.), Immunology of Infectious Disease
    2011 - 2016
  • University of Illinois at Urbana-Champaign
    Bachelor of Science (B.S.) with High Distinction, Chemistry
    2007 - 2010

Community

You need to have a working account to view this content. Click here to join now